Research programme: apoptosis inducers - Aponetics AGAlternative Names: Apo 1; Apo 2; Apo 3; APO1-4; Apoptosis inducers research programme: Aponetics AG
Latest Information Update: 14 Mar 2007
At a glance
- Originator Aponetics
- Mechanism of Action Apoptosis stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 25 Nov 2004 Discontinued - Preclinical for Cancer in Switzerland (unspecified route)
- 25 Mar 2004 Preclinical trials in Cancer in Switzerland (unspecified route)